Travere Therapeutics, Inc. (TVTX) › RevenueTravere Therapeutics, Inc. (TVTX) — RevenueAnnual figures by fiscal year, from SEC filings.2016: $133.59M2017: $154.94M2018: $164.25M2019: $175.34M2020: $198.32M2021: $131.84M2022: $109.46M2023: $145.24M2024: $233.18M2025: $490.73M$490.73M2016Revenue (USD)2025Fiscal YearRevenueChange YoY2025$490.73M+110.5%2024$233.18M+60.5%2023$145.24M+32.7%2022$109.46M-17.0%2021$131.84M-33.5%2020$198.32M+13.1%2019$175.34M+6.8%2018$164.25M+6.0%2017$154.94M+16.0%2016$133.59M—Other metrics: Cost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share